Trends in Clinical Pharmacology and Therapeutics

Iris K Minichmayr^#¹, D Max Smith^#^{2

3}, Kathleen M Giacomini⁴, Piet H van der Graaf^{5

6}

Affiliations

¹ Medical University of Vienna, Vienna, Austria.
² MedStar Health, Columbia, Maryland, USA.
³ Georgetown University Medical Center, Washington, DC, USA.
⁴ Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
⁵ Certara, Canterbury, UK.
⁶ University of Leiden, Leiden, The Netherlands.

^# Contributed equally.

Editorial

Iris K Minichmayr et al. Clin Pharmacol Ther. 2023 Jul.

. 2023 Jul;114(1):11-14.

doi: 10.1002/cpt.2931.

Iris K Minichmayr^#¹, D Max Smith^#^{2

3}, Kathleen M Giacomini⁴, Piet H van der Graaf^{5

6}

¹ Medical University of Vienna, Vienna, Austria.
² MedStar Health, Columbia, Maryland, USA.
³ Georgetown University Medical Center, Washington, DC, USA.
⁴ Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
⁵ Certara, Canterbury, UK.
⁶ University of Leiden, Leiden, The Netherlands.

^# Contributed equally.

No abstract available

References

1. ASCPT. Everything you Wanted to Know about ASCPT's Editor-in-Training Program [webinar] <https://vimeo.com/683875157>. February 2022
1. Honig, P.K. The “coming of age” of real-world evidence in drug development and regulation. Clin. Pharmacol. Ther. 111, 11-14 (2022).
1. Honig, P.K. Real-world evidence and the regulation of medicines. Clin. Pharmacol. Ther. 109, 1169-1172 (2021).
1. Venkatakrishnan, K., Brown, K.E., Giacomini, K.M. & van der Graaf, P.H. Diversity, equity, and inclusion: translating clinical pharmacology for all. Clin. Pharmacol. Ther. 113, 457-461 (2023).
1. van der Graaf, P.H. Diversity in clinical pharmacology and therapeutics. Clin. Pharmacol. Ther. 110, 837-840 (2021).